Sabé M
Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, Chemin du Petit-Bel-Air, CH-1226, Thonex, Switzerland. michel.sabe@hug.ch.
ArticlePsilocybin
Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.
ArticlePsilocybin
Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.
ArticlePsilocybin
Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.
PreprintPsilocybin
Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland
ArticleMDMA
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.
ArticlePsilocybin
[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]
ArticlePsilocybin
Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.
ArticlePsychedelics
Reconsidering evidence for psychedelic-induced psychosis: An overview of reviews, a systematic review, and meta-analysis of human studies
ArticlePsychedelics
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.
ArticlePsilocybin
Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.
ArticlePsilocybin
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.
ArticlePsilocybin
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.
ArticleKetamine